Synovus price target lowered to $39 from $42 at Barclays

Barclays lowered the firm’s price target on Synovus to $39 from $42 and keeps an Equal Weight rating on the shares post the Q1 report. The company’s broader guidance was reiterated but more first half of 2024 net interest margin pressure and continued credit normalization are negatives for the stock, the analyst tells investors in a research note.